Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985.
D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000150:complications; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D010397:Penicillanic Acid / Q000494:pharmacology / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D010608:Pharyngeal Diseases / Q000188:drug therapy; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D000198:Spectinomycin / Q000494:pharmacology / Q000627:therapeutic use; D013407:Sulbactam; D013587:Syphilis / Q000150:complications; D013752:Tetracycline / Q000494:pharmacology / Q000627:therapeutic use
D002511:Cephalosporins; D002969:Clavulanic Acids; D010406:Penicillins; D011804:Quinolines; D019818:Clavulanic Acid; D010397:Penicillanic Acid; D000198:Spectinomycin; D013752:Tetracycline; D013407:Sulbactam